Regulatory Agencies Establish Principles of Good AI Use in Drug Development

Objective:

To establish guiding principles for the responsible use of AI in drug development, ensuring patient safety and therapeutic benefit.

Key Findings:

• AI can accelerate drug development and enhance pharmacovigilance, but oversight is crucial to mitigate risks.
• There is a risk of generating unreliable results without proper oversight.
• The principles promote a human-centric approach and risk-based assessments.

Interpretation:

The proposed framework aims to integrate AI responsibly in drug development while addressing specific ethical, legal, and technical standards.

Limitations:

• The principles are guidelines and may require further regulatory and legal policies.
• Implementation may vary across different organizations and jurisdictions, potentially affecting their effectiveness.

Conclusion:

The 10 principles provide a foundation for the responsible use of AI in drug development, emphasizing safety and ethical considerations.